Irit Arbel, Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 2,500 shares at $4.26 ($11K) on 2017-08-31, disclosed to the SEC on 2017-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.